Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Ayrat Kaldarov is a leading surgeon specializing in minimally invasive and robotic-assisted oncology, with a particular focus on complex abdominal and retroperitoneal tumors. His major contributions lie in advancing the application of robotic surgery for rare and technically demanding conditions, including retroperitoneal masses, pancreatic neuroendocrine tumors, and vascular leiomyosarcomas. Dr. Kaldarov has demonstrated the feasibility and safety of robot-assisted pancreatoduodenectomy and two-stage combined treatments for iliac vein sarcomas, often publishing comparative studies that highlight the advantages of robotic techniques over conventional laparoscopy and laparotomy. His work on organic hyperinsulinism and proinsulin-secreting pancreatic neuroendocrine tumors has refined diagnostic and surgical strategies for these rare endocrine conditions. With multiple papers receiving 5–8 citations, his research on the cost-effectiveness of robotic surgery has also informed healthcare policy. Notably, his 2017 study on retroperitoneal masses (8 citations) and his 2020 comparative analysis of robotic surgery for retroperitoneal tumors (8 citations) are foundational references in the field. Dr. Kaldarov’s commitment to improving surgical outcomes through innovation makes him a key figure in the evolution of robotic oncologic surgery.